1 Market Overview of Intravenous (IV) Iron Therapy 1.1 Intravenous (IV) Iron Therapy Market Overview 1.1.1 Intravenous (IV) Iron Therapy Product Scope 1.1.2 Intravenous (IV) Iron Therapy Market Status and Outlook 1.2 Global Intravenous (IV) Iron Therapy Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Intravenous (IV) Iron Therapy Market Size by Region (2016-2027) 1.4 Global Intravenous (IV) Iron Therapy Historic Market Size by Region (2016-2021) 1.5 Global Intravenous (IV) Iron Therapy Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Intravenous (IV) Iron Therapy Market Size (2016-2027) 1.6.1 North America Intravenous (IV) Iron Therapy Market Size (2016-2027) 1.6.2 Europe Intravenous (IV) Iron Therapy Market Size (2016-2027) 1.6.3 Asia-Pacific Intravenous (IV) Iron Therapy Market Size (2016-2027) 1.6.4 Latin America Intravenous (IV) Iron Therapy Market Size (2016-2027) 1.6.5 Middle East & Africa Intravenous (IV) Iron Therapy Market Size (2016-2027) 2 Intravenous (IV) Iron Therapy Market Overview by Type 2.1 Global Intravenous (IV) Iron Therapy Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Intravenous (IV) Iron Therapy Historic Market Size by Type (2016-2021) 2.3 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Type (2022-2027) 2.4 Ferric Carboxymaltose 2.5 Iron Sucrose 2.6 Iron Dextran 2.7 Others 3 Intravenous (IV) Iron Therapy Market Overview by Application 3.1 Global Intravenous (IV) Iron Therapy Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Intravenous (IV) Iron Therapy Historic Market Size by Application (2016-2021) 3.3 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2022-2027) 3.4 Nephrology 3.5 Gynecology & Obstetrics 3.6 Gastroenterology 3.7 Oncology 3.8 Cardiology 3.9 Others 4 Intravenous (IV) Iron Therapy Competition Analysis by Players 4.1 Global Intravenous (IV) Iron Therapy Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Therapy as of 2020) 4.3 Date of Key Players Enter into Intravenous (IV) Iron Therapy Market 4.4 Global Top Players Intravenous (IV) Iron Therapy Headquarters and Area Served 4.5 Key Players Intravenous (IV) Iron Therapy Product Solution and Service 4.6 Competitive Status 4.6.1 Intravenous (IV) Iron Therapy Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Sanofi 5.1.1 Sanofi Profile 5.1.2 Sanofi Main Business 5.1.3 Sanofi Intravenous (IV) Iron Therapy Products, Services and Solutions 5.1.4 Sanofi Intravenous (IV) Iron Therapy Revenue (US$ Million) & (2016-2021) 5.1.5 Sanofi Recent Developments 5.2 Allergan 5.2.1 Allergan Profile 5.2.2 Allergan Main Business 5.2.3 Allergan Intravenous (IV) Iron Therapy Products, Services and Solutions 5.2.4 Allergan Intravenous (IV) Iron Therapy Revenue (US$ Million) & (2016-2021) 5.2.5 Allergan Recent Developments 5.3 AMAG Pharmaceuticals 5.5.1 AMAG Pharmaceuticals Profile 5.3.2 AMAG Pharmaceuticals Main Business 5.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Products, Services and Solutions 5.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue (US$ Million) & (2016-2021) 5.3.5 Dalichi Sankyo Recent Developments 5.4 Dalichi Sankyo 5.4.1 Dalichi Sankyo Profile 5.4.2 Dalichi Sankyo Main Business 5.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Products, Services and Solutions 5.4.4 Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue (US$ Million) & (2016-2021) 5.4.5 Dalichi Sankyo Recent Developments 5.5 Luitpold Pharmaceuticals 5.5.1 Luitpold Pharmaceuticals Profile 5.5.2 Luitpold Pharmaceuticals Main Business 5.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Products, Services and Solutions 5.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue (US$ Million) & (2016-2021) 5.5.5 Luitpold Pharmaceuticals Recent Developments 5.6 Pharmacosmos 5.6.1 Pharmacosmos Profile 5.6.2 Pharmacosmos Main Business 5.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Products, Services and Solutions 5.6.4 Pharmacosmos Intravenous (IV) Iron Therapy Revenue (US$ Million) & (2016-2021) 5.6.5 Pharmacosmos Recent Developments 5.7 Takeda Pharmaceutical 5.7.1 Takeda Pharmaceutical Profile 5.7.2 Takeda Pharmaceutical Main Business 5.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Products, Services and Solutions 5.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue (US$ Million) & (2016-2021) 5.7.5 Takeda Pharmaceutical Recent Developments ... 6 North America 6.1 North America Intravenous (IV) Iron Therapy Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Intravenous (IV) Iron Therapy Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Intravenous (IV) Iron Therapy Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Intravenous (IV) Iron Therapy Market Dynamics 11.1 Intravenous (IV) Iron Therapy Industry Trends 11.2 Intravenous (IV) Iron Therapy Market Drivers 11.3 Intravenous (IV) Iron Therapy Market Challenges 11.4 Intravenous (IV) Iron Therapy Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Intravenous (IV) Iron Therapy Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Intravenous (IV) Iron Therapy Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Intravenous (IV) Iron Therapy Market Size Share by Region (2016-2021) Table 4. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Intravenous (IV) Iron Therapy Forecasted Market Size Share by Region (2022-2027) Table 6. Global Intravenous (IV) Iron Therapy Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Intravenous (IV) Iron Therapy Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2016-2021) Table 9. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2022-2027) Table 11. Global Intravenous (IV) Iron Therapy Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Intravenous (IV) Iron Therapy Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2016-2021) Table 14. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2022-2027) Table 16. Global Intravenous (IV) Iron Therapy Revenue (US$ Million) by Players (2016-2021) Table 17. Global Intravenous (IV) Iron Therapy Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Therapy as of 2020) Table 19. Date of Key Manufacturers Enter into Intravenous (IV) Iron Therapy Market Table 20. Global Intravenous (IV) Iron Therapy Top Players Headquarters and Area Served Table 21. Intravenous (IV) Iron Therapy Product Solution and Service Table 22. Global Intravenous (IV) Iron Therapy Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Sanofi Basic Information List Table 25. Sanofi Description and Business Overview Table 26. Sanofi Intravenous (IV) Iron Therapy Products, Services and Solutions Table 27. Revenue (US$ Million) in Intravenous (IV) Iron Therapy Business of Sanofi (2016-2021) Table 28. Sanofi Recent Developments Table 29. Allergan Basic Information List Table 30. Allergan Description and Business Overview Table 31. Allergan Intravenous (IV) Iron Therapy Products, Services and Solutions Table 32. Revenue (US$ Million) in Intravenous (IV) Iron Therapy Business of Allergan (2016-2021) Table 33. Allergan Recent Developments Table 34. AMAG Pharmaceuticals Basic Information List Table 35. AMAG Pharmaceuticals Description and Business Overview Table 36. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Products, Services and Solutions Table 37. Revenue (US$ Million) in Intravenous (IV) Iron Therapy Business of AMAG Pharmaceuticals (2016-2021) Table 38. AMAG Pharmaceuticals Recent Developments Table 39. Dalichi Sankyo Basic Information List Table 40. Dalichi Sankyo Description and Business Overview Table 41. Dalichi Sankyo Intravenous (IV) Iron Therapy Products, Services and Solutions Table 42. Revenue (US$ Million) in Intravenous (IV) Iron Therapy Business of Dalichi Sankyo (2016-2021) Table 43. Dalichi Sankyo Recent Developments Table 44. Luitpold Pharmaceuticals Basic Information List Table 45. Luitpold Pharmaceuticals Description and Business Overview Table 46. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Products, Services and Solutions Table 47. Revenue (US$ Million) in Intravenous (IV) Iron Therapy Business of Luitpold Pharmaceuticals (2016-2021) Table 48. Luitpold Pharmaceuticals Recent Developments Table 49. Pharmacosmos Basic Information List Table 50. Pharmacosmos Description and Business Overview Table 51. Pharmacosmos Intravenous (IV) Iron Therapy Products, Services and Solutions Table 52. Revenue (US$ Million) in Intravenous (IV) Iron Therapy Business of Pharmacosmos (2016-2021) Table 53. Pharmacosmos Recent Developments Table 54. Takeda Pharmaceutical Basic Information List Table 55. Takeda Pharmaceutical Description and Business Overview Table 56. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Products, Services and Solutions Table 57. Revenue (US$ Million) in Intravenous (IV) Iron Therapy Business of Takeda Pharmaceutical (2016-2021) Table 58. Takeda Pharmaceutical Recent Developments Table 59. North America Intravenous (IV) Iron Therapy Market Size by Country (2016-2021) & (US$ Million) Table 60. North America Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million) Table 61. Europe Intravenous (IV) Iron Therapy Market Size by Country (2016-2021) & (US$ Million) Table 62. Europe Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million) Table 63. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2016-2021) & (US$ Million) Table 64. Asia-Pacific Intravenous (IV) Iron Therapy Market Size by Region (2022-2027) & (US$ Million) Table 65. Asia-Pacific Intravenous (IV) Iron Therapy Market Share by Region (2016-2021) Table 66. Asia-Pacific Intravenous (IV) Iron Therapy Market Share by Region (2022-2027) Table 67. Latin America Intravenous (IV) Iron Therapy Market Size by Country (2016-2021) & (US$ Million) Table 68. Latin America Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million) Table 69. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Players (2016-2021) & (US$ Million) Table 70. Middle East & Africa Intravenous (IV) Iron Therapy Market Size by Country (2022-2027) & (US$ Million) Table 71. Intravenous (IV) Iron Therapy Market Trends Table 72. Intravenous (IV) Iron Therapy Market Drivers Table 73. Intravenous (IV) Iron Therapy Market Challenges Table 74. Intravenous (IV) Iron Therapy Market Restraints Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Global Intravenous (IV) Iron Therapy Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Intravenous (IV) Iron Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Intravenous (IV) Iron Therapy Market Share by Regions: 2021 VS 2027 Figure 4. Global Intravenous (IV) Iron Therapy Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Intravenous (IV) Iron Therapy Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Intravenous (IV) Iron Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Intravenous (IV) Iron Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Intravenous (IV) Iron Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Intravenous (IV) Iron Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Intravenous (IV) Iron Therapy Market Size Share by Type in 2021 & 2027 Figure 11. Ferric Carboxymaltose Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Iron Sucrose Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Iron Dextran Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Intravenous (IV) Iron Therapy Market Size Share by Application in 2021 & 2027 Figure 16. Nephrology Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Gynecology & Obstetrics Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Gastroenterology Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Oncology Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Cardiology Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 22. Intravenous (IV) Iron Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Top 5 and Top 10 Players Intravenous (IV) Iron Therapy Market Share in 2020 Figure 24. North America Intravenous (IV) Iron Therapy Market Share by Country (2016-2027) Figure 25. United States Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 26. Canada Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 27. Germany Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 28. France Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 29. U.K. Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 30. Italy Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 31. Russia Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 32. Nordic Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 33. Rest of Europe Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Intravenous (IV) Iron Therapy Market Share by Region (2016-2027) Figure 35. China Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 36. Japan Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 37. South Korea Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 38. Southeast Asia Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 39. India Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 40. Australia Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Asia-Pacific Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 42. Latin America Intravenous (IV) Iron Therapy Market Share by Country (2016-2027) Figure 43. Mexico Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 44. Brazil Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Latin America Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 46. Middle East & Africa Intravenous (IV) Iron Therapy Market Share by Country (2016-2027) Figure 47. Turkey Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 48. Saudi Arabia Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 49. UAE Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 50. Rest of Middle East & Africa Intravenous (IV) Iron Therapy Market Size (2016-2027) & (US$ Million) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation

Sanofi Allergan AMAG Pharmaceuticals Dalichi Sankyo Luitpold Pharmaceuticals Pharmacosmos Takeda Pharmaceutical